Below are 8 legal actions involving members of the drug supply chain, including others, drugmakers and pharmacists, reported by Beckers Hospital Review because August:.
West Virginia pharmacist faces jail for wire scams, cash launderingWest Virginia pharmacist Natalie Cochran, PharmD, pleaded guilty to one count of wire scams and one count of money laundering, U.S. Attorney Mike Stuart revealed.
AstraZeneca loses claim accusing it of monopolizing antipsychotic drugA Dutch payer has actually won a claim implicating AstraZeneca of developing an unreasonable monopoly on an antipsychotic drug by utilizing a patent that had actually been invalidated to block generic competition.
Maia Anderson –
Thursday, October 22nd, 2020
Mississippi drug store owners charged in $18M health care scams schemeTwo Mississippi drug store owners have actually been implicated of paying and receiving kickbacks and other kickbacks in exchange for promoting expensive compounded drugs and dispensing them to people who didnt require them in an $18 million health care scams plan.
Drugmakers, PBMs should collectively face insulin price-fixing claim, judge rulesA suit implicating several drugmakers and drug store advantage supervisors of conspiring to fix rates for insulin can proceed, a Texas judge ruled, marking the very first time drugmakers and PBMs will need to jointly defend their function in the increasing rate of insulin.
Gilead settles kickback claims for $97MGilead agreed to pay a $97 million settlement for accusations it used a charity to pay unlawful kickbacks to Medicare clients to cover copays for its hypertension drug Letairis.
3 former drug store execs indicted in $50M healthcare fraud schemeThree former executives of a Louisiana compounding drug store were arraigned in a $50 million scheme to defraud New Jersey and military health benefits programs.
© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.
United States takes legal action against Teva for 2nd time in 1 week, this time in alleged price-fixing schemeThe U.S. on Aug. 25 charged Teva Pharmaceuticals with conspiring with other generic drugmakers to increase costs for the drugs they make.
Novartis, Roche fined $528M for anti-competition plan in FranceNovartis and Roche have actually been fined a cumulative $528 million by Frances anti-trust regulator for apparently conspiring to promote the pricey eye illness treatment Lucentis over a less costly drug.
More posts on drug store:7 measures hospitals, drugmakers are requiring to avoid COVID-19 vaccine thefts12 drugs being evaluated as COVID-19 treatmentsParticipant in AstraZenecas Brazil COVID-19 trial who died didnt get vaccine.
© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by click on this link.